首页> 外国专利> 2-(R2-THIO)-10-3-(4-R1-PIPERAZINE-1-YL)PROPYL-10H-PHENOTHIAZINE FOR TREATING β-AMYLOIDOPATHY OR α-SYNUCLEINOPATHY, AND METHOD FOR DIAGNOSIS OR PRE-DIAGNOSIS OF β-AMYLOIDOPATHY OR α-SYNUCLEINOPATHY

2-(R2-THIO)-10-3-(4-R1-PIPERAZINE-1-YL)PROPYL-10H-PHENOTHIAZINE FOR TREATING β-AMYLOIDOPATHY OR α-SYNUCLEINOPATHY, AND METHOD FOR DIAGNOSIS OR PRE-DIAGNOSIS OF β-AMYLOIDOPATHY OR α-SYNUCLEINOPATHY

机译:2-(R2-THIO)-10- [3-(4-R1-哌嗪-1-基)丙基] -10H-苯并噻嗪治疗β-淀粉样变性或α-突触核蛋白病,以及诊断或诊断β的方法-肌病或α-突触核病

摘要

PROBLEM TO BE SOLVED: To provide a method for treatment of β-amyloidopathy or α-synucleinopathy accompanying brain protein precipitate and activity reduction of a brain ABCC1-transporter such as Alzheimer-type dementia, Parkinson disease or Lewy body dementia or the like, and a method for determining risk of developing the diseases.SOLUTION: The above described diseases are treated by using a compound exemplified by 2-(ethylthio)-10-[3-(4-methylpiperazine-1-yl)propyl]-10H-phenothiazine. A risk of developing the diseases is evaluated by analyzing substrates transferred via a brain ABCC1 transporter and accumulated.SELECTED DRAWING: None
机译:解决的问题:提供一种治疗β-淀粉样变性或α-突触核蛋白变性伴随脑蛋白沉淀并降低脑ABCC1转运蛋白如阿尔茨海默氏型痴呆,帕金森病或路易体痴呆等的方法,解决方案:通过使用以下化合物治疗上述疾病:2-(乙硫基)-10- [3-(4-甲基哌嗪-1-基)丙基] -10H-吩噻嗪。通过分析通过脑ABCC1转运蛋白转移并积累的底物来评估患病的风险。

著录项

  • 公开/公告号JP2017019776A

    专利类型

  • 公开/公告日2017-01-26

    原文格式PDF

  • 申请/专利权人 IMMUNOGENETICS AG;

    申请/专利号JP20160131781

  • 发明设计人 JENS PANCKE;

    申请日2016-07-01

  • 分类号C07D279/28;A61P39/02;A61P25/28;A61P25/16;A61P43;A61K31/5415;A61K31/495;A61K45;G01N33/50;

  • 国家 JP

  • 入库时间 2022-08-21 14:01:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号